clinical trial

Education found to help with MS treatment adherence in Iran

An educational intervention program was found to help improve treatment adherence among people with multiple sclerosis (MS) receiving injectable therapies in a clinical trial in Iran. The program was designed based on the theory of planned behavior ā€” a psychological premise that assumes people act rationally according to their…

Treatments with electrical nerve stimulation ease pain in small trial

Transcutaneous electrical nerve stimulation (TENS) and interferential currents (IFC) ā€” both interventions apply electrical stimulation through electrodes placed on the skin ā€” can help to ease pain in people with multiple sclerosis (MS), according to results from a small clinical trial. Results suggested that, while both treatments can reduce…

Trial Testing Safety, Efficacy of Ginger Supplements in RRMS

Researchers in Iran are conducting a clinical trial to test the effects of taking ginger supplements for people with relapsing-remitting multiple sclerosis (RRMS). Ginger extracts have shown some promise in animal models of multiple sclerosis (MS), but no trial has yet determined the impact that ginger supplements may…

Researchers Share Strategies to Improve Clinical Trial Recruitment

Publicity in national news outlets and an online self-screening questionnaire helped improve recruitment for a clinical trial in secondary progressive multiple sclerosis (SPMS), a new study highlights. “We have described our experience of recruiting participants with SPMS into two large RCTs [randomized clinical trials] in order to identify areas…

Cionic Collaborates With Fuseproject on Neural Sleeve

Cionic has collaborated with the multidisciplinary design firm fuseproject to further develop its artificial intelligence-powered, wearable Neural Sleeve, which improves mobility for those living with conditions such as multiple sclerosis (MS). The partnership with Yves Behar and his firm fuseproject resulted in a design that focuses on…

EMBOLD Study of ATA188 in Progressive MS Is Given Go-ahead

An independent committee of experts has recommended that the Phase 2 portion of the EMBOLD clinical trial continue as planned without a sample size adjustment, following an analysis of safety and effectiveness data. The trial is testing Atara Biotherapeutics‘ experimental medication ATA188 in progressive forms of multiple…

Keto Diet Improved Life Quality of RRMS Patients in Trial

Eating a ketogenic diet ā€” one low in carbohydrates and high in fats ā€” led to markedly less fatigue and depression for people with relapsing-remitting multiple sclerosis (RRMS) in a small clinical trial that was designed to assess the tolerability of the dietary intervention. Measures of disability and quality…

Trial of Metformin-Clemastine Combo Enrolls First Patient

The first participant has been enrolled in a new clinical trial that is testing whether an antihistamine in combination with a diabetes medication might promote the repair of the myelin sheath in people with multiple sclerosis (MS). The trial’s first participant, Annabelle, was diagnosed with relapsing MS over a…

At 64, I’m Surprised to Be Scrambling to Mount a Chariot

As usual, Iā€™ve gone for what I hope to be an intriguing headline, because youā€™ve got to grab a reader by any means necessary. If youā€™ve read this far, Iā€™m winning! This saga goes back well over a year, when my neurologist suggested I participate in a clinical trial for…

An Epstein-Barr Virus Primer for MS Patients

You may have heard about the research that’s just been published about the Epstein-Barr virus (EBV) and multiple sclerosis (MS). The Harvard T.H. Chan School of Public Health study reports that being infected by EBV raises the risk of developing MS by 32 times. This isn’t a small or…

Study Probes Why Some Don’t Experience Placebo Effect

Differences in the physical architecture of the brain may explain why some people with multiple sclerosis (MS), but not others, experience a placebo effect, according to a new study. The results suggest that MS itself may make some individuals unable to experience the benefits of a placebo. “Our findings…

Acthar Gel May Help RRMS Patients Who Fail Corticosteroids

Acthar Gel (repository corticotropin injection) may be useful for managing disease relapses in people with relapsing-remitting multiple sclerosis (RRMS) who fail to respond to treatment with corticosteroids, according to results from a small clinical trial. The study, “Results from a multicenter, randomized, double-blind, placebo-controlled study…